Profile
CLGN VRTX REGN ALNY SGEN ARGX
Company Name CollPlant Biotechnologies Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $30.26M $100.25B $60.38B $59.29B $43.15B $40.18B
Employees 0.06K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Yehiel Tal Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
CLGN VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 3 4 1 3 4
Quant Rating Strong Sell Neutral Buy Strong Sell Neutral Buy
Trading
CLGN VRTX REGN ALNY SGEN ARGX
Last Close $2.62 $391.02 $580.7 $446.51 $228.74 $712.2
High 52 $5.39 $516.74 $1184.69 $467.71 $228.74 $712.2
Low 52 $1.35 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -51.39 % -24.33 % -50.98 % -4.53 % 0 % 0 %
Price vs. 52 Week Low 94.07 % 6.68 % 20.25 % 98.82 % 0 % 38.5 %
Total Return
CLGN VRTX REGN ALNY SGEN ARGX
1 Month Return 14.39 % -15.39 % 3.91 % 11.13 % 0 % 5.7 %
3 Month Return 12.45 % -12.22 % 18.37 % 45.88 % 0 % 21.83 %
6 Month Return -25.14 % -18.5 % -16.89 % 80.96 % 0 % 14.01 %
9 Month Return -40.18 % -16.04 % -23.83 % 76.48 % 0 % 15.34 %
YTD Return -27.22 % -2.9 % -18.48 % 89.75 % 0 % 15.8 %
1 Year Return -50.52 % -21.15 % -50.98 % 69.98 % 0 % 37.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CLGN VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.46 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -49.92 % 11.09 % 4.37 % -0.43 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 2.64 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Profitability
CLGN VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 52.25 % 86.11 % 81.98 % 83.64 % 79.1 % 65.32 %
Return on Assets TTM -74.57 % 15.13 % 11.67 % -6.99 % -16.61 % 15.06 %
Return on Equity TTM -94.08 % 22.14 % 15.11 % -274.21 % -20.8 % 18.96 %
Return on Capital Employed TTM -90.79 % 19.72 % 11.45 % -5.52 % -21.46 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 91.46 % 84.06 % 101.33 % 237.3 %
EBT Per Ebit TTM 97.46 % 111.48 % 123.23 % 210.66 % 98.26 % 147.38 %
EBIT Per Revenue TTM -555.45 % 34.36 % 27.83 % -7.32 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -348.08 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.03 2.53 4.34 3.91 1.91
Payables Turnover TTM 2.01 0.43 3.54 3.93 1.97 0.88
Inventory Turnover TTM 2.07 1.06 0.8 5.62 0.96 2.21
Fixed Asset Turnover TTM 52.43 % 431.08 % 293.64 % 355.68 % 665.41 % 5009.77 %
Asset Turnover TTM 13.78 % 47.51 % 37.19 % 53.92 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -0.89 14.98 45.13 -0.12 -2.46 -1.07
Free Cash Flow Per Share TTM -0.91 13.63 36.58 -0.4 -2.88 -1.09
Cash Per Share TTM 98.87 % 3036 % 7107.14 % 2203.63 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -438.65 % 33.68 % 33.37 % -0.63 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 102 % 90.99 % 81.05 % 335.21 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -348.08 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -2.82 28.65 15.7 -1138.28 -81.26 -520.99
Price To Operating Cash Flows Ratio TTM -2.94 26.1 12.84 -3774.78 -93.1 -617.61
Price Cash Flow Ratio TTM -2.94 26.1 12.84 -3774.78 -93.1 -617.61
Income Statement (TTM)
CLGN VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio -215.53% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.02B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1.45 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
CLGN VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.02B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
CLGN VRTX REGN ALNY SGEN ARGX
Net Income $-0.02B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.79
AARD Aardvark Therapeutics, Inc. Common Stock 8.79
ABCL AbCellera Biologics Inc. 4.0941
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.865
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.355
ABPWW 0.035
ABSI Absci Corporation 2.35
ABUS Arbutus Biopharma Corporation 3.855
ABVC ABVC BioPharma, Inc. 2.683
ABVX Abivax SA American Depositary Shares 81.3756
ACAD ACADIA Pharmaceuticals Inc. 26
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7365
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.895
ACIU AC Immune SA 2.2138
Unlock